Intas Pharmaceuticals Ltd.

Intas Pharmaceuticals, Ltd. is a global leader in developing, manufacturing, and marketing generics, biosimilars, and added value medicines. In 2023-24, it achieved USD 2.4Bn in sales, operating in over 85 countries. About 70% of its revenue comes from international markets, especially the EU and US.

Intas has four GMP sites in India, two in the UK, one in Mexico, and one in Greece, producing various pharmaceutical forms. It is vertically integrated into APIs for key products. From a total workforce of 19,000 employees, Intas dedicates more than 550 to R&D in wo...